| Cat. No. |
Product Name |
Information |
| PC-27426 |
Faldoritinib
FLT3 inhibitor
|
Faldoritinib is a potent, selective FLT3 inhibitor. |
| PC-26900 |
FYJ-195
FLT3 inhibitor
|
FYJ-195 is a highly potent type II FLT3 inhibitor with IC50 of 2.03 nM for FLT3-ITD, overcomes recalcitrant gatekeeper F691L and activation loop D835V/Y variants. |
| PC-26471 |
FLC-8
FLT3 inhibitor
|
FLC-8 is a potent, selective and covalent FLT3 inhibitor with IC50 of 10.2 nM, 11.6 nM and 24.1 nM for FLT3-WT, FLT3 G697R and FLT3 N676D respectively. |
| PC-26046 |
AMG 925
CDK4/FLT3 inhibitor
|
AMG 925 (AMG925, AMG-925) is a potent and orally bioavailable dual inhibitor of CDK4 and FLT3 with IC50 of 3 nM and 1 nM for CDK4/Cyclin D1 and FLT3 respectively. |
| PC-25800 |
FN-1501
FLT3 inhibitor
|
FN-1501 (FN1501) is a potent FLT3 and CDK inhibitor with IC50 of 0.27 nM, 2.47 nM, 0.85 nM and 1.96 nM for FLT3, CDK2/cyclin A, CDK4/cyclin D1, and CDK6/cyclin D1 respectively, induces collapsin response mediator protein 2 (CRMP2) dephosphorylation in breast cancer cells. |
| PC-25422 |
PLM-101 hydrochloride
FLT3/RET inhibitor
|
PLM-101 hydrochloride is a synthetic derivative of indirubin and potent, dual FLT3/RET inhibitor with IC50 of 0.565 nM and 0.849 nM for FLT3-ITD and RET kinase respectively. |
| PC-25421 |
PLM-101
FLT3/RET inhibitor
|
PLM-101 is a synthetic derivative of indirubin and potent, dual FLT3/RET inhibitor with IC50 of 0.565 nM and 0.849 nM for FLT3-ITD and RET kinase respectively. PLM-101 inhibits the proliferation of Ba/F3 cells expressing FLT3-ITD-mutant kinases at the nanomolar (nM) concentration levels. |
| PC-24959 |
CCT241736
FLT3/Aurora kinase inhibitor
|
CCT241736 (Mobinitinib) is a potent, orally bioavailable dual FLT3/Aurora kinase inhibitor with binding Kd of 7.5/48/6.2/38/14 nM for Aurora-A/Aurora-B/FLT3 WT/FLT3-ITD/FLT3(D835Y) respectively. |
| PC-24406 |
Clifutinib besylate
FLT3-ITD inhibitor
|
Clifutinib besylate (HEC73543) is potent, selective FLT3-ITD (internal tandem duplication mutations of FLT3) inhibitor with biochemical IC50 of 15.1 nM, exhibits significant antiproliferative activity against Ba/F3-FLT3-ITD cells with IC50 of 0.9 nM. |
| PC-23629 |
Danatinib
FLT3 inhibitor
|
Danatinib is a potent and selective FLT3 inhibitor with IC50 of 3 nM, overcomes acquired resistance and shows effective inhibition against FLT3-ITD and/or FLT3-TKD mutations. |
| PC-21367 |
FLT3 inhibitor 17
FLT3 inhibitor
|
FLT3 inhibitor 17 is a potent, highly selective FLT3 inhibitor with IC50 of 1.2 nM and 1.4 nM for FLT3 WT and FLT3-D835Y, shows low activity against VEGFR, FGFR, PDGFR, c-KIT, and RET. |